Obesity Study - Use of oral hCG for treatment of obesity: A double-blind study References

Powered by:

The oral hCG Resarch Clinic invites you to:

The first International Workshop on hCG and obesity

We offer a variety of advertising opportunities to promote your products or services. Options range from banners and buttons to streaming video on a custom branded player.

To contact us::
Toll-free (US only):+1-888-472-2001
Telephone: +1- 714-671-9180

More information regarding our promotional Programs

For more general information on advertising, please refer to this page.

Use of oral hCG for treatment of obesity: A double-blind study
References

1	Albrink MJ.	Chorionic gonadotropin and obesity? Am J Nutr Clin Nutr 22(6): 681-685, 1969.
2	Asher WL, Harper HW:	Effect of human chorionic gonadotropin on weight loss, hunger and feeling of well-being. Am J Nutr 26:211-218, 1973.
3	Ballin JC, Write PL.	Fallacy and hazard: HCG, 500-Kcal diet and weight reduction. J Am Med Assoc 230(5):693-694, 1974.
4	Berger M, et al	[Is HCG therapy obesity warranted]? 0723-5003. 1980 Aug 15; 75(17): 624-625. Review. German.
5	Bernstein L, et al.	Treatment with human chorionic gonadotropin and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 1995 Jul; 4(5): 437-440.
6	Birmingham L, Smith K.	Human chorionic gonadotropin is of no value in the management of obesity. Can Med Assoc J 128:1156-1157, 1983.
7	Bosch B, et al.	Human chorionic gonadotrophin and weight loss. A double-blind, placebo-controlled trial. S Afr Med J. 1990 Feb 17; 77(4): 185-189
8	Boyer A.	L'hCG dans I'obésité: non, non et non! Med Quebec Juin: 81-82, 1976.
9	Bradley P	Chorionic gonadotrophin (HCG) and obesity.Med J Aust 1977 Oct 22;2(17):581
10	Bradley P.	'The equilibrium set-point weight: human chorionic gonadotrophin and obesity'. Int J Obes. 1979; 3(4): 380-389.
11	Bradley P.	Human chorionic gonadotropin in weight reduction [letter]. Am J Clin Nutr. 1977 May; 30(5): 649-654.
12	Briguglio FS.	[Further contribution to the treatment of cryptogenic ulcerative colitis with chorionic gonadotropin]. Minerva Gastroenterol. 1965 Jul; 11(3): 145-150. Itali
13	Cargille CM.	Human chorionic gonadotropin not indicated for obesity. J Am Med Assoc 219(111): 1485-1486, 1972.
14	Carne S.	The action of chorionic gonadotropin in the obese. Lancet II: 1282-1284, 1961.
15	Ceresa F.	La terapie con ormone gonadotrope coriale e con tiroide delle distrofie adiposo-ipersomicheipo-e normogenital dell'adolescente. Clin. Ter 4:24-40,1953.
16	Craig LS, Ray RE, Waxler SH, Madigan H.	Chorionic gonadotropin in the treatment of obese women. Am J Clin Nutr 12:230-234, 1963.
17	Dietz RE, LaCroix E.:	Roundtable: Drug therapy in obesity, Part II. Ob Bar Med 9(1): 15-25, 1980.
11	Dunn CE.	Human chorionic gonadotropin for weight reduction. Am J Obstet Gynecol 120: 855, 1974.
12	Faludi G.	Use of chorionic gonadotropins in obesity. Am Fam Physician. 1975 May; 11(5): 156-157.
13	Fleigelman R, Fried GH.:	Metabolic effect of human chorionic gonadotropin (hCG) in rats. Proc Soc Exp Biol Med 135: 317-319, 1970.
14	Frank BW.	The use of chorionic gonadotropin hormone in the treatment of obesity. Am J Clin Nutr 14: 133-136, 1964.
15	Greenway FL, Bray GA.:	Human chorionic gonadotropin in the treatment of obesity, West J Med 127: 461.463, 1977.
16	Gusman HA.	Chorionic gonadotropin in obesity. Further clinical observations. Am J Clin Nutr. 1969 Jun; 22(6): 686-695.
17	Hashimoto T, Sawai T.	Chorionic gonadotropin as an analgesic (letter). Arch Int Med 141:269, 1981.
18	Hirsch J, Van Itallie TB.	The treatment of obesity. Am J Clin 26: 1039-1041, 1973.
19	Hutton JH, et al.	Human chorionic gonadotropin (HCG) in treatment of obesity. IMJ Ill Med J. 1967 Nov; 132(5): 693-695
20	Hutton JH.	Chorionic gonadotropin and obesity. Am J Clin Nutr. 1970 Mar; 23(3): 243-244.
21	Kolata G.	Obesity declared a disease. Science 227(4690): 1019-1020, 1985.
22	Komarnicka R, et al.	[Results of treatment of obesity with low calorie diet and additional drugs]. Przegl Lek. 1975; 32(11): 814-817. Polish.
23	Lebon P.	The treatment of obesity. Dist Nurs. 1967 Mar; 9(12): 286-288.
24	Loskant G.	[Human chorionic gonadotropin]. Ther Ggw. 1969 Mar; 108(3): 376. German.
25	Maudlin RK.	Gonadotropins in obesity? Am Fam Physician. 1973 Oct; 8(4): 202-203.
26	Miller R, Schneiderman LJ.	A clinical study of the use of human chorionic gonadotropin in weight reduction. J Fam Pract 4(3): 445-448, 1977.
27	Munro JF.	Drug treatment of obesity: an overview. Int J Obes. 1987; 11 Suppl 3: 13-15. Review.
28	NIH (National Institutes of Health, USA).	Consensus panel: Health implications of obesity. Ann Inter Med 103: 147-151, 1985.
29	Perelberg H.:	Chorionic gonadotropin and obesity. Med J Austr 64(2): 68-69. 1977.
30	Rath R, et al.	[Use of choriogonadotropin in the treatment of obesity]. Vnitr Lek. 1974 Jul; 20(7): 681-685. Czech.
21	Rivlin RS.:	Therapy of obesity with hormones. N Engl J Med Jan 2: 26-29, 1975.
31	Scaffidi V.	[Chorionic gonadotropin in the treatment of atherosclerosis]. Clin Eur. 1965 Nov; 4(6): 429-432. Italian.
32	Shetty RK, Kalkhoff.:	Human chorionic gonadotropin treatment of obesity. Arch Intern Med 137: 151-155, 1977.
33	Simeons ATW.	Pounds and Inches : a new approach to obesity. Private printing, 1974.
34	Simeons ATW.	The action of chorionic gonadotropin in the obese. Lancet II: 946-947, 1954.
35	Sohar E.	A forty-day 550-calorie diet in the treatment of obese outpatients. Am J Nutr 7:514-518, 1959.
36	Stein MR, Julis RE, Peck CC, Hinshaw W, Sawicki JE, Deller JJ.	Ineffectiveness of human chorionic gonadotropin in weight reduction: a double blind study. Am J Clin Nutr 29:940-948, 1976.
37	Vallini A, et al.	Treatment of obesity with chorionic gonadotropins. Relations between obesity, dyslipidemia and arthero-arteriosclerosis. Minerva Med. 1976 Jul 7; 67(33): 2113-2132. Italian.
38	Vasiukova EA, et al.	[Obesity]. Klin Med (Mosk). 1977 Apr; 55(4): 124-127. Russian.
39	Veilleux H, et al.	[Gonadic and extragonadic effects in humans of 3,500 I.U. of HCG (human chorionic gonadotropin) in fractional doses]. Vie Med Can Fr. 1972 Sep; 1(9): 862-871. French.
40	Vogt, T; Belluscio, D	Controversies in Plastic Surgery :SAL (Suction Assisted Lipectomy and the hCG protocol for the management of obesity) Aesth. Pl. Surg 11:131-156, 1987
41	Yanagihara Y.	[Carbohydrate and fatty acid metabolism in pregnant albino rats simultaneously loaded with fat emulsion and sex stimulating hormones during starvation]. Nippon Sanka Fujinka Gakkai Zasshi. 1967 Jan; 19(1): 8-14. Japanese. No abstract available.
42	Yanagihara Y.	[Carbohydrate and lipid metabolism in pregnant albino rats during starvation after loading with gonad-stimulating hormones]. Nippon Sanka Fujinka Gakkai Zasshi. 1966 Dec; 18(12): 1379-1384. Japanese.
43	Yanagihara Y.	[Carbohydrate and lipid metabolism in pregnant albino rats during hunger after loading with gonad-stimulating hormones]. Nippon Sanka Fujinka Gakkai Zasshi. 1966 Nov; 18(11): 1293-1301. Japanese.
44	Young RL, et al.	Chorionic gonadotropin in weight control. A double-blind crossover study. JAMA. 1976 Nov 29; 236(22): 2495-2497.

International Workshop on hCG (Human Coriogonadotropin) and obesity)
September 24-26 2004 Buenos Aires, Argentina

Terms of Use

A joint project of Indexmedico and InterSol, Inc.

Questions? Comments?

15/05/2007

The oral hCG Resarch Clinic invites you to: The first International Workshop on hCG and obesity

Use of oral hCG for treatment of obesity: A double-blind study References

International Workshop on hCG (Human Coriogonadotropin) and obesity) September 24-26 2004 Buenos Aires, Argentina

Questions? Comments?

The oral hCG Resarch Clinic invites you to:

The first International Workshop on hCG and obesity

Use of oral hCG for treatment of obesity: A double-blind study
References

International Workshop on hCG (Human Coriogonadotropin) and obesity)
September 24-26 2004 Buenos Aires, Argentina